Rexulti 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FCK7Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,702
Award facts
- Contract value 100% obligated
- $1,701.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Rexulti 1 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,701.72. This is a non-set-aside competitive award with an ultimate completion date of October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense Logistics Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's competitive positioning and proven capability to fulfill federal medical procurement requirements through the Defense Logistics Agency's pharmaceutical prime vendor program underscores its critical role in supporting Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FCK7Q?
SPE2DR26FCK7Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FCK7Q worth?
The government has obligated $1,702 on SPE2DR26FCK7Q.
Is contract SPE2DR26FCK7Q an order under another contract?
Yes. SPE2DR26FCK7Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCK7Q competed?
The extent of competition for SPE2DR26FCK7Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award